Metal complex and method for producing hydrogen peroxide
US-9522824-B2 · Dec 20, 2016 · US
US10125158B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10125158-B2 |
| Application number | US-201515503822-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 28, 2015 |
| Priority date | Sep 19, 2014 |
| Publication date | Nov 13, 2018 |
| Grant date | Nov 13, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for manufacturing tris(β-diketonato)iridium by reacting β-diketone with an iridium compound, in which an activation treatment including (a) an alkali treatment and (b) an acid treatment described below is applied to the iridium compound to activate the iridium compound, and to subsequently react the β-diketone, (a) an alkali treatment: a treatment of adding alkali to a solution of the iridium compound to raise pH of the solution to a more alkaline side than that before the alkali addition and to not less than 10, and (b) an acid treatment: a treatment of adding acid to the solution subjected to the alkali treatment to lower pH of the solution to a more acidic side than that before the acid addition and to make the pH difference between solutions before and after the acid addition be not less than 0.1 and not more than 10. The present invention allows manufacture of tris(β-diketonato)iridium utilizing a wide variety of β-diketones.
Opening claim text (preview).
The invention claimed is: 1. A method for manufacturing tris(β-diketonato)iridium shown by Chem 2 in which a β-diketone is coordinated to iridium, by reacting the β-diketone shown by Chem 1 with an iridium compound which is any one of iridium nitrate (III, IV), iridium chloride (III, IV), and ammonium hexachloroiridate (III, IV), wherein an activation treatment including (a) an alkali treatment and (b) an acid treatment described below is applied to the iridium compound to activate the iridium compound, and to subsequently react the β-diketone, (a) an alkali treatment: a treatment of adding alkali to a solution of the iridium compound to raise pH of the solution to a more alkaline side than that before the alkali addition and to not less than 10, and (b) an acid treatment: a treatment of adding acid to the solution subjected to the alkali treatment to lower pH of the solution to a more acidic side than that before the acid addition and to make the pH difference between solutions before and after the acid addition be not less than 0.1 and not more than 10, wherein each of Ra and Rb is a hydrocarbon group or substituents in which a hydrogen atom in a hydrocarbon group is substituted by a halogen atom, Ra and Rb may be different substituents, or identical substituents, Rc is a substituent composed of any of a hydrogen atom, a halogen atom and a hydrocarbon group; and wherein Ra, Rb, and Rc have the same meaning as in Chem 1. 2. The method for manufacturing tris(β-diketonato)iridium according to claim 1 , wherein pH after alkali addition in the alkali treatment (a) is set to not less than 12. 3. The method for manufacturing tris(β-diketonato)iridium according to claim 1 , wherein the pH difference between solutions before and after the alkali addition in the alkali treatment (a) is set to not less than 2 and not more than 13. 4. The method for manufacturing tris(β-diketonato)iridium according to claim 1 , wherein the pH difference between solutions before and after the acid addition in the acid treatment (b) is set to not less than 1 and not more than 10. 5. The method for manufacturing tris(β-diketonato)iridium according to claim 2 , wherein the pH difference between solutions before and after the alkali addition in the alkali treatment (a) is set to not less than 2 and not more than 13. 6. The method for manufacturing tris(β-diketonato)iridium according to claim 2 , wherein the pH difference between solutions before and after the acid addition in the acid treatment (b) is set to not less than 1 and not more than 10. 7. The method for manufacturing tris(β-diketonato)iridium according to claim 3 , wherein the pH difference between solutions before and after the acid addition in the acid treatment (b) is set to not less than 1 and not more than 10.
of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd · CPC title
characterized by the use of precursors specially adapted for ALD · CPC title
containing organic luminescent materials · CPC title
Electricity · mapped topic
from metallo-organic compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.